highly effective disease-modifying therapies for multiple sclerosis
Published 7 years ago • 6.3K plays • Length 31:37Download video MP4
Download video MP3
Similar videos
-
45:02
clinical implications of late-breaking data on disease modifying therapies for ms management
-
40:44
harnessing the full potential of dmt mechanisms of action to improve ms outcomes
-
20:42
aan releases guideline: disease-modifying therapies for adults with multiple sclerosis
-
1:00:54
re-examining s1pr modulation from all angles in relapsing multiple sclerosis
-
2:07
guideline: disease modifying therapies for multiple sclerosis - american academy of neurology
-
1:05:12
disease modifying therapies in multiple sclerosis
-
38:37
ms treatment decisions before, during, and after pregnancy
-
2:15
a pni minute | disease modifying therapies (dmts) for the treatment of multiple sclerosis
-
5:21
what to expect from disease modifying therapies for multiple sclerosis
-
14:49
“choosing the right disease-modifying therapy,” geeta ganesh, m.d.
-
32:35
targeting btk in the treatment of patients with ms
-
1:19:58
guiding patients through the risks and benefits of disease-modifying therapy
-
42:59
taking stock of late-breaking data on disease-modifying therapies for ms: key learnings from berlin
-
1:23:16
disease modifying therapies
-
29:38
leveraging the power of anti-cd20 mabs in patient-centric multiple sclerosis care
-
26:57
b-cell therapies in relapsing ms: clarifying the options in an expanding treatment landscape
-
50:02
exploring the rationale, results, and real-world clinical potential of btki in the management of ms
-
41:30
potential clinical implications of latest data on approved & emerging dmts for ms: recap from paris
-
57:39
advances in s1pr modulation: progress in understanding brain atrophy and cognition measures in ms